NICE director exercises options for 696 shares
NICE Ltd. director Simon Zehava exercised stock options to acquire 696 Ordinary Shares on May 13, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NICE Ltd. director Simon Zehava exercised stock options to acquire 696 Ordinary Shares on May 13, 2026. The options carried an exercise price of 0.2929 per share and were fully vested and exercisable. Following the transaction, Zehava directly holds 4,135 Ordinary Shares of NICE Ltd.
Insider Trade Summary
696 shares exercised/converted
Exercise
2 txns
Insider
Simon Zehava
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Options | 696 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 696 | $0.2929 | $203.86 |
Holdings After Transaction:
Options — 0 contracts (Direct);
Ordinary Shares — 4,135 shares (Direct)
Footnotes (1)
- F1. The stock option is fully vested and currently exercisable.
Key Figures
Shares acquired via option exercise: 696 shares
Option exercise price: 0.2929 per share
Shares held after transaction: 4,135 shares
+2 more
5 metrics
Shares acquired via option exercise
696 shares
Ordinary Shares acquired on May 13, 2026
Option exercise price
0.2929 per share
Exercise price for 696 options
Shares held after transaction
4,135 shares
Total Ordinary Shares directly held post-transaction
Options exercised
696 options
Derivative position converted into Ordinary Shares
Option expiration date
September 10, 2026
Original expiration date of exercised options
Key Terms
stock option, derivative security, Ordinary Shares, exercise price
4 terms
stock option financial
"The stock option is fully vested and currently exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise price financial
"conversion_or_exercise_price: 0.2929"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NICE (NICE) disclose for Simon Zehava?
NICE disclosed that director Simon Zehava exercised stock options to acquire 696 Ordinary Shares. The options were fully vested and exercisable, and the exercise increased Zehava’s directly held position in NICE Ltd. to 4,135 Ordinary Shares after the transaction.
What was the exercise price of the options used by NICE director Simon Zehava?
The options exercised by director Simon Zehava had an exercise price of 0.2929 per share. These options were fully vested and currently exercisable, and their conversion on May 13, 2026 resulted in 696 new Ordinary Shares of NICE Ltd. being acquired.
Did the NICE (NICE) Form 4 show any open-market buying or selling by Simon Zehava?
The Form 4 reports an exercise of derivative securities, not open-market trades. Director Simon Zehava converted 696 options into Ordinary Shares, with no separate buy or sell code transactions reported, and now directly holds 4,135 Ordinary Shares of NICE Ltd.
What happened to the options after Simon Zehava’s exercise at NICE (NICE)?
The derivative line in the filing shows 696 options exercised into 696 Ordinary Shares. After this exercise, the remaining balance for that option grant is zero, indicating the options were fully used, with an expiration date previously set for September 10, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates